Rundong Keruohua Pharmaceutical Research & Development (Shanghai) Co., Ltd. is a joint venture between a Chinese and a Japanese pharmaceutical R&D company, established in Shanghai with the aim of enhancing collaboration in drug development between the two nations. The pharmaceutical industry is known for its high costs, long timelines, and significant risks, especially given the critical nature of human health and safety. In response to these challenges, many countries have continuously updated their drug regulations to ensure higher standards of quality and safety.
Currently, Contract Research Organizations (CROs) play a vital role in the global pharmaceutical landscape. These specialized institutions help manage the complexities of drug development, ensuring quality control, reducing risks, and offering expert services to biopharmaceutical companies. As a result, CROs have become essential partners in bringing new medicines to market efficiently and safely.
Rundong Pharmaceutical Research & Development (Shanghai) Co., Ltd. has emerged as one of the fastest-growing CROs in China in recent years. The company not only conducts clinical research but also collaborates with various institutions to provide training in Good Clinical Practice (GCP). On the other side of the Pacific, CRONOVA Co., Ltd. stands out as Japan’s only CRO that has successfully achieved all four major industry certifications. It is also recognized as one of the top-performing and fastest-growing CROs in Japan, highlighting its strong reputation and expertise.
Guo Yunpei, Vice President of the China Pharmaceutical Quality Management Association, who attended the company's inauguration, emphasized the rapid growth of China’s pharmaceutical market. However, he noted that intense competition has led to a mixed environment, where only a few local companies maintain strict quality standards. He pointed out that the successful partnership between Rundong and Japan’s CRONOVA Inc. offers more than just market expansion—it brings together the strengths of both Chinese and Japanese pharmaceutical industries. This collaboration fosters better resource sharing, aligns quality standards, and provides crucial technical support for delivering high-quality drugs to the market more quickly.
Light Duty Long Span Shelving,Rivet Rack,Boltless Rack,Plastic Storage Shelves
Suzhou Aomeijia Metalic Products Co,Ltd. , https://www.amjshelf.com